Mangalam Drugs & Organics
MANGALAMNSE

Mangalam Drugs & Organics

₹28.29-0.57 (1.98%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
27.51
Today’s high
29.48
52 week low
22.80
52 week high
95.00
Open price
28.29
Previous close
28.86
Live volume
35,239
Lower circuit
26.88
Upper circuit
29.70

Fundamentals

Market Cap
₹46Cr
ROE
-43.08%
P/E Ratio(TTM)
--
EPS(TTM)
-28.05
P/B Ratio
0.48
Dividend Yield
0.00%
Industry P/E
33.73
Book Value
60.64
Debt to Equity
1.02
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹67.38
+14.98%
Profit (Cr)
-₹13.42
-36.38%
-250255075
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26

About

Mangalam Drugs & Organics Limited is a premier Indian manufacturer of Active Pharmaceutical Ingredients (APIs), supplying world-class products to the pharmaceutical sector. The company's focused efforts are designed to provide a competitive edge in the ever-evolving pharmaceutical landscape. It prioritizes customer satisfaction and diligently follows regulatory requirements, ensuring its products have a positive impact on the industries it serves. Its state-of-the-art manufacturing sites at Vapi are mainly focused on producing advanced intermediates for APIs, in compliance with high quality benchmarks. A strong backward integration strategy for key raw materials is the foundation of its dominant position in the industry. The company also has a global presence, with its products available in countries like Italy, Russia, China, Turkey, Nigeria, and Pakistan.;
CEO/MD
Shri Govardhan M. Dhoot
Founded in
1972
NSE symbol
MANGALAM

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
64.02%
Promoters
35.65%
Foreign Institutions
0.32%
2026
14
May
Annual Result
Release date
15
Jan
Quarterly Result
Release date
2025
20
Nov
Quarterly Result
Release date
13
Nov
Quarterly Result
Release date
7
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks